Grant: Project Grant
University of Alberta
$1,137,940.00
Alphavirus-host interactions: Toward novel antiviral therapies.
EF 2018-19
Résumé
Mosquitoes are the deadliest animals on earth as they transmit a wide-variety of diseases to humans, many of which are caused by viruses. Together, mosquito-transmitted viruses infect more than >400 million people annually causing hundreds of thousands of deaths. Moreover, the incidence of mosquito-transmitted diseases is increasing dramatically in part due to climate change and urban sprawl. There are few vaccines or therapeutics for mosquito-borne viruses and as such, there is an urgent need for novel antiviral strategies. In the present application, we focus on a newly emerging and rapidly spreading group of mosquito-transmitted alphaviruses (Mayaro (MAYV) and Chikungunya (CHIKV) viruses), that cause severe and chronic arthritis.
Understanding how viral infection modulates the cellular environment will shed light onto the sequence of events leading to chronic joint inflammation and pain. The proposed studies will form the basis for new therapies that block replication and transmission of MAYV and CHIKV.
Programme
Project Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
388100
Name
Hobman Tom C
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Virology & Viral Pathogenesis
Projecttitle
Alphavirus-host interactions: Toward novel antiviral therapies.
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$1,137,940
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antiviral; Arthritis; Chikungunya Virus; Interactome; Mayaro Virus; Protease; Transcriptomics
Abstract
Mosquitoes are the deadliest animals on earth as they transmit a wide-variety of diseases to humans, many of which are caused by viruses. Together, mosquito-transmitted viruses infect more than >400 million people annually causing hundreds of thousands of deaths. Moreover, the incidence of mosquito-transmitted diseases is increasing dramatically in part due to climate change and urban sprawl. There are few vaccines or therapeutics for mosquito-borne viruses and as such, there is an urgent need for novel antiviral strategies. In the present application, we focus on a newly emerging and rapidly spreading group of mosquito-transmitted alphaviruses (Mayaro (MAYV) and Chikungunya (CHIKV) viruses), that cause severe and chronic arthritis.
Understanding how viral infection modulates the cellular environment will shed light onto the sequence of events leading to chronic joint inflammation and pain. The proposed studies will form the basis for new therapies that block replication and transmission of MAYV and CHIKV.
Competitiondate
201809
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Hobman, Tom C
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,137,940~ $0~